Osteoporosis

Among women aged 40 to 64 years, a recent major osteoporotic fracture was associated with increased risk for a repeat fracture at 10 years, with highest risk within the first 2 years of the fracture, according to study data.

Bone loss is a natural part of aging — especially due to menopause for women — but certain cancer treatments and prolonged cancer survival can increase the risk for bone loss and the related outcome of fractures.

Compared with other first-line osteoporosis treatments, alendronate therapy yielded an increased risk for depression and anxiety, according to an analysis of adverse events reports.

High levels of body fat are associated with a lower bone mineral density, with the association more pronounced in men compared with women, according to study data published in The Journal of Clinical Endocrinology & Metabolism.

Health care costs remained high for Medicare beneficiaries with common chronic conditions for which brand-name medications without generic alternatives were recommended, according to findings published in JAMA Internal Medicine.

The Healio and Endocrine Today editors have compiled the top news about bone and mineral metabolism in 2021.

Research continued to explore new treatments for vasomotor symptoms, the connections between menopause and cardiovascular and bone health and more in 2021. Here are the top stories from Healio’s coverage throughout the year.

Endocrine Today editors have compiled the top cover stories published in 2021.

Despite potential side effects, bisphosphonate therapy may benefit postmenopausal women with osteoporosis by preventing fractures, according to a study published in JAMA Internal Medicine.

Early identification and timely intervention are key to treating children with glucocorticoid-induced osteoporosis, a preventive strategy outlined in five important principles by a speaker at ACR Convergence 2021.